3sbio revenue was ¥6.38 b in FY, 2021
|FY, 2018||FY, 2019||FY, 2020||FY, 2021|
|Revenue||¥4.58 b||¥5.32 b||¥5.59 b||¥6.38 b|
3sbio revenue breakdown by business segment: 100.0% from PHARMACEUTICAL DIVERSIFIED
|FY, 2021||FY, 2020||FY, 2019||FY, 2018|
|PHARMACEUTICAL DIVERSIFIED||¥6.38 m||¥5.59 m||¥5.32 m||¥4.58 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.